Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Share-based Compensation (2016 - 2025)

Icu Medical (ICUI) has disclosed Share-based Compensation for 17 consecutive years, with $13.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 10.88% year-over-year to $13.9 million, compared with a TTM value of $55.8 million through Dec 2025, up 18.93%, and an annual FY2025 reading of $55.8 million, up 18.93% over the prior year.
  • Share-based Compensation was $13.9 million for Q4 2025 at Icu Medical, down from $15.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $15.2 million in Q3 2025 and bottomed at $6.0 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $10.3 million, with a median of $10.8 million recorded in 2023.
  • The sharpest move saw Share-based Compensation surged 100.8% in 2022, then fell 24.26% in 2023.
  • Year by year, Share-based Compensation stood at $8.1 million in 2021, then dropped by 8.35% to $7.4 million in 2022, then soared by 43.85% to $10.7 million in 2023, then rose by 17.15% to $12.5 million in 2024, then grew by 10.88% to $13.9 million in 2025.
  • Business Quant data shows Share-based Compensation for ICUI at $13.9 million in Q4 2025, $15.2 million in Q3 2025, and $14.5 million in Q2 2025.